about
The notch ligand JAGGED1 as a target for anti-tumor therapyJagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosisAlagille syndrome: pathogenesis, diagnosis and managementAlagille syndrome: clinical perspectivesIdentification of new human mastermind proteins defines a family that consists of positive regulators for notch signalingExon 6 of human Jagged-1 encodes an autonomously folding unitNovel Heterozygous Mutations in JAG1 and NOTCH2 Genes in a Neonatal Patient with Alagille Syndrome.Conditional JAG1 mutation shows the developing heart is more sensitive than developing liver to JAG1 dosageRbm24a and Rbm24b are required for normal somitogenesis.Structural biology. Structural basis for Notch1 engagement of Delta-like 4Consequences of JAG1 mutations.Disorders caused by chromosome abnormalities.JAG1 Mutation Spectrum and Origin in Chinese Children with Clinical Features of Alagille Syndrome.JAGGED1 gene variations in Chinese twin sisters with Alagille syndrome.The role of notch in modeling and maintaining the vasculature.Chromosome deletion of 14q32.33 detected by array comparative genomic hybridization in a patient with features of dubowitz syndromeAlagille syndrome and a JAG1 mutation: 41 cases of experience at a single centerCritical region in 2q31.2q32.3 deletion syndrome: Report of two phenotypically distinct patients, one with an additional deletion in Alagille syndrome region.Jagged1 heterozygosity in mice results in a congenital cholangiopathy which is reversed by concomitant deletion of one copy of Poglut1 (Rumi)An autosomal recessive form of Alagille-like syndrome that is not linked to JAG1.The genetics and ocular findings of Alagille syndrome.THBS2 Is a Candidate Modifier of Liver Disease Severity in Alagille SyndromeFamilial deafness, congenital heart defects, and posterior embryotoxon caused by cysteine substitution in the first epidermal-growth-factor-like domain of jagged 1.Notch signaling in cardiac valve development and disease.Molecular pathways of notch signaling in vascular smooth muscle cells.Renal involvement and the role of Notch signalling in Alagille syndrome.Cardiac outflow tract anomalies.Novel resequencing chip customized to diagnose mutations in patients with inherited syndromes of intrahepatic cholestasisNotch Signaling in Vascular Smooth Muscle Cells.Modeling SNP mediated differential targeting of homologous 3'UTR by microRNA.NOTCH2 mutations in Alagille syndrome.Adult-onset renal failure in a family with Alagille syndrome with proteinuria and a novel JAG1 mutation.MicroRNA‑141 inhibits the self‑renewal of glioblastoma stem cells via Jagged1Clinical utility gene card for: Alagille Syndrome (ALGS)A case of Alagille syndrome presenting with chronic cholestasis in an adult.A 10-year-old child presenting with syndromic paucity of bile ducts (Alagille syndrome): a case report.Human hepatic organoids for the analysis of human genetic diseases.Notch activation suppresses fibroblast growth factor-dependent cellular transformation.The tetralogy of Fallot-associated G274D mutation impairs folding of the second epidermal growth factor repeat in Jagged-1.Prolonged neonatal jaundice: When to worry and what to do.
P2860
Q21129294-CD4DAF8D-6D95-41C4-9384-4FEBD312A7F0Q24309460-5DC31068-A9EB-49DB-878B-5ABB8C1AC7DAQ24631094-498E1621-033A-4CD8-A01A-7D4FF2FBDB2BQ26740224-6A6BD3B2-6991-4244-9A10-A29E70EDAF93Q28208323-219E22A6-6F42-4C15-8EF9-B3FE65E0FB3FQ28281367-0835754E-FF7D-4CFD-8D89-2C7F41F2A942Q33561122-D86EFB2D-7BDC-4746-9FD0-42CFC5F42A98Q33905006-6839E830-BDF3-47D5-B26A-4B900ADF034DQ34109905-404F2D90-E3DA-4075-9081-D529EB5D212CQ34463833-4238882A-EF40-4C0F-9F86-13D68F7B401CQ34544044-8CA93D0C-CD6D-469A-BC21-9997DCD64C3DQ34775497-C73CE222-F359-4599-8268-5A1E718E132CQ35664014-414F5706-E872-4EFB-8E45-2E47B81ECE32Q36014490-D78FD8F3-7D12-4EF2-8048-6A7A2234216BQ36067007-78D996E9-7DA1-461D-9011-74AFAA317036Q36248022-19828171-6179-4BF5-8660-7DC9C1F4F468Q36279898-632B3BA8-FA15-4947-8146-17D9D8D28556Q36287023-22F33329-25FB-409C-B5C8-B2097AABC213Q36479429-20721D86-739A-4E85-9A7B-2C79F2E38DC4Q36911080-CAD68B15-EBB4-4F1D-8A35-BC4D213DA8EDQ37039785-DB0A822F-8860-43E8-8F90-AB125D2FD78BQ37297770-28E21BE9-E191-40E8-9A2F-FE46FA9A1D30Q37362001-DF0B84A2-10FA-49AD-9AE8-388C01B3C3BEQ37874571-D8052F56-8CD6-4B42-832D-07599EE0495BQ38003146-4F7A842B-4B38-4C69-8AA6-0545E9DA5410Q38113456-99544671-D294-4EB6-BE32-81554091AA10Q38135363-93A9FBD2-0E69-4021-BEBB-0E62C4846EC9Q38305536-53C0DCDD-06A9-466A-B6C8-FE5001FD39FDQ39141059-F1360241-E78E-4E12-95A4-DF0DCB99B5E8Q39396247-F0156A81-D224-4AC4-8B06-9C8C608D8700Q39419524-738EF1A4-2A59-4FC8-8082-920AA927A11FQ39719276-7D01CA52-E964-4FBD-B248-30186E513496Q41059804-25E1CB24-4731-40C8-8C64-051AC114DE28Q41764251-176003A8-EDBE-4959-9549-C842D7FF939FQ41945095-C9BCFF8C-69FA-46FC-AAB6-6DDA83245141Q42359783-CA040CFE-3016-4F5C-94F4-816FAA4CAA79Q42367643-1F2882D4-9F28-4285-9A26-B7937CFA0034Q42804897-FC89F37F-00FF-42C4-8BB5-97676E54E53EQ42833630-98F19F15-54DD-4150-86C1-E691466099CAQ43074027-57BAD73B-6973-4BBF-A1DE-A411DDC1FD48
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Jagged1 mutations in alagille syndrome.
@ast
Jagged1 mutations in alagille syndrome.
@en
Jagged1 mutations in alagille syndrome.
@nl
type
label
Jagged1 mutations in alagille syndrome.
@ast
Jagged1 mutations in alagille syndrome.
@en
Jagged1 mutations in alagille syndrome.
@nl
prefLabel
Jagged1 mutations in alagille syndrome.
@ast
Jagged1 mutations in alagille syndrome.
@en
Jagged1 mutations in alagille syndrome.
@nl
P2093
P2860
P1433
P1476
Jagged1 mutations in alagille syndrome.
@en
P2093
C Crosnier
I D Krantz
M Hadchouel
M Meunier-Rotival
N B Spinner
R P Colliton
P2860
P356
10.1002/1098-1004(2001)17:1<18::AID-HUMU3>3.0.CO;2-T
P577
2001-01-01T00:00:00Z